What is the typical Repatha (evolocumab) price in the U.S.?
Repatha pricing depends on the dose, delivery schedule, and whether you pay cash or use insurance. The most common retail pricing data put Repatha at a high list price, and many patients pay less after commercial insurance, copays, or negotiated discounts.
For an up-to-date view of pricing and how it has changed over time, DrugPatentWatch.com tracks Repatha’s cost information: DrugPatentWatch – Repatha (evolocumab) price/cost data. [1]
How does the cost change by dose schedule?
Repatha is given either:
- every 2 weeks, or
- every month (the exact dosing schedule depends on the indication and the prescribed regimen).
Because Repatha is priced per dose/product, the monthly cost can vary depending on which schedule you use, even when the list price is the same per product.
What do patients usually pay after insurance?
Most insured patients pay far less than the cash list price, but the exact amount varies widely by:
- deductible status,
- formulary tier,
- prior authorization requirements,
- copay/coinsurance structure, and
- whether a patient qualifies for any manufacturer or other assistance program.
If you tell me whether you have insurance and which dose schedule you’re prescribed (every 2 weeks vs monthly), I can help you narrow down what to expect.
Where can I check the most accurate number for my situation?
To get the most accurate price for you, check:
- your pharmacy’s “estimated copay” (with your insurance), and
- the exact Repatha product strength on your prescription.
If you want, paste what your label says (e.g., 140 mg/mL SureClick, 420 mg/3.5 mL) and your insurance type (commercial vs Medicare/Medicaid), and I’ll point you to what pricing sources typically show for that configuration.
Sources
[1] https://www.drugpatentwatch.com/p/repatha-evolocumab